Blue Trust Inc. Has $517,000 Stock Position in Alignment Healthcare, Inc. $ALHC

Blue Trust Inc. lifted its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 48.4% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 36,912 shares of the company’s stock after buying an additional 12,045 shares during the period. Blue Trust Inc.’s holdings in Alignment Healthcare were worth $517,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. MCF Advisors LLC grew its stake in Alignment Healthcare by 87.6% in the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after buying an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new stake in Alignment Healthcare in the 1st quarter worth $42,000. Signaturefd LLC grew its position in Alignment Healthcare by 142.6% in the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock worth $53,000 after purchasing an additional 2,215 shares during the last quarter. Amalgamated Bank grew its position in Alignment Healthcare by 21.6% in the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock worth $65,000 after purchasing an additional 616 shares during the last quarter. Finally, Greenleaf Trust acquired a new stake in shares of Alignment Healthcare during the 2nd quarter valued at about $160,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on ALHC shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, October 8th. KeyCorp raised shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price target for the company in a report on Monday, August 25th. Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a report on Monday, September 29th. Wall Street Zen downgraded shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, August 10th. Finally, Barclays raised shares of Alignment Healthcare from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Two equities research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $18.83.

Insiders Place Their Bets

In related news, President Dawn Christine Maroney sold 215,662 shares of the firm’s stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $3,539,013.42. Following the completion of the transaction, the president owned 1,797,237 shares in the company, valued at $29,492,659.17. This trade represents a 10.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Hyong Kim sold 51,379 shares of the firm’s stock in a transaction that occurred on Thursday, October 9th. The stock was sold at an average price of $17.57, for a total transaction of $902,729.03. Following the transaction, the insider owned 362,333 shares of the company’s stock, valued at approximately $6,366,190.81. The trade was a 12.42% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 7,263,207 shares of company stock worth $116,735,880 over the last quarter. 6.60% of the stock is currently owned by corporate insiders.

Alignment Healthcare Stock Performance

Shares of ALHC stock opened at $17.31 on Monday. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. The company’s fifty day simple moving average is $16.06 and its 200-day simple moving average is $15.64. Alignment Healthcare, Inc. has a 12 month low of $10.11 and a 12 month high of $21.06. The firm has a market cap of $3.43 billion, a PE ratio of -61.82 and a beta of 1.18.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. During the same period in the prior year, the firm earned ($0.13) earnings per share. The company’s revenue was up 49.0% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.